在耐火性中,VNS诱导的剂量依赖的瞳孔反应
Andrés Torres Sánchez1, Marie Dawant2, Venethia Danthine3
1Institute of Neuroscience (IoNS), Catholic University of Louvain, Brussels, Belgium; Innoviris, Brussels Institute for Research and Innovation, Chaussée de Charleroi 112, 1060, Brussels, Belgium.
概括
迷你神经刺激 (VNS) 导致剂量依赖的瞳孔扩张反应 (PDR),在响应者和不响应者之间存在差异,这表明PDR是VNS治疗的新生物标志物.
科学领域:
- 神经科学是一个神经科学.
- 的研究研究.
- 生物标志物开发 生物标志物开发
背景情况:
- 核心部位 (Locus Coeruleus,LC) 释放诺阿基因,有助于神经刺激 (VNS) 的抗作用.
- 腰椎活动会影响瞳孔膨胀,这可能与VNS的有效性有关.
研究的目的:
- 调查VNS强度和瞳孔扩展反应 (PDR) 之间的剂量依赖关系.
- 探索PDR作为优化VNS治疗和预测患者反应的客观生物标志物.
主要方法:
- 对14名植入VNS的患者 (9名反应者,5名不反应者) 的回顾性分析.
- VNS强度从0.25mA变化到2.25mA,同时跟踪瞳孔大小.
- 个体曲线适配分析了VNS强度与PDR关系.
主要成果:
- 随着VNS强度的增加,瞳孔膨胀反应 (PDR) 增加,特别是在响应者中.
- 在6名患者中观察到一个反转的U形VNS强度-PDR关系.
- 确定了VNS强度和响应者状态之间的显著相互作用,独立于主观感知.
结论:
- VNS引发了剂量依赖的PDR,可以区分响应者和不响应者.
- 在近一半的患者中,反转的U形剂量反应曲线表明最大VNS效应.
- 由VNS诱导的PDR被提出为VNS治疗反应的新和客观生物标志物.
相关概念视频
Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
Drugs Acting on Autonomic Ganglia: Stimulants
Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating sympathetic or...
Local Anesthetics: Adverse Effects
While local anesthetics are generally safe and well-tolerated, they can occasionally cause adverse effects that vary in severity. Local anesthetics can induce toxicity at two distinct levels. They can either produce local effects through direct contact with the neural elements or be absorbed into the bloodstream from the injection site, leading to systemic effects.
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Once absorbed into the systemic circulation, local anesthetics can affect the organs that depend on the functioning of sodium...
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates these...
Drug Toxicity: Dose-Dependent Reactions
Drug toxicities can be stratified into pharmacological, pathological, or genotoxic based on their mechanisms. The incidence and severity of these toxicities generally increase with the drug's concentration in the body and exposure time.Pharmacological toxicity is evident when the therapeutic effects of drugs overshoot into adverse reactions in a predictable, dose-dependent manner. Central nervous system (CNS) depression from barbiturates is a classic example, with effects escalating from...
Drug Toxicity: Allergic Reactions
Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial exposure to a...


